Head of Investor Relations
Teva Pharmaceutical Industries Ltd (TEVA)Equibles does not estimate personal net worth.
Get an email with a short summary when Teva Pharmaceutical Industries Ltd publishes a filing, an earnings call transcript or a press release.
Get TEVA alertsChris Stevo is recorded as Head of Investor Relations at Teva Pharmaceutical Industries Ltd (TEVA). Chris Stevo has spoken on 5 earnings calls and 1 other investor event across 1 company, most recently for Teva Pharmaceutical Industries Ltd on October 9, 2026. Teva Pharmaceutical Industries Ltd is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Teva Pharmaceutical Industries Ltd includes Richard Francis (CEO and Board Member), Eli Kalif (CFO), Amir Weiss (Chief Accounting Officer) and 7 others.
“Thank you for joining us on short notice to discuss the US FDA approval of Welltruza, Lanzapine LAI. The materials are posted to the website this morning, and the press release is also on our website.”
“I'd like to note that before we posted our press release this morning on earnings, we also posted a press release on the MLX transaction as well as the slide deck relating to that transaction.”
“Before I turn it over to our CEO, Richard Francis, I just want to remind everyone that we will be making forward-looking statements on this call. Any statements we make are only as of today, and we undertake no obligation to update those statements subsequently.”
“In a moment, I'll hand the call over to my CEO, Richard Francis. But before I do that, it is my duty and my honor to remind you of our forward-looking statements.”
“On this call, we'll be making forward-looking statements, and we disclaim any obligation to update those statements after today's call.”
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
